Compact, Easily-scalable Capsules for Virus Removal and Small-scale Membrane Qualification Studies

Pegasus SV4 Virus Removal filters combine robust, high viral clearance of parvovirus and larger viruses with high throughput capacity and stable flowrates in both dilute and complex, concentrated biological fluids. Consistent flowrate and throughput performance provide superior control of process costs and maximize virus filtration economy and efficiency.

Pall Minidisc Capsules with Pegasus SV4 Virus Removal Filter Membrane are purpose-designed for small-scale membrane qualification studies such as bacteriophage or prion (TSE agent) clearance, as well as membrane flow rate, capacity and protein transmission studies. They are 100% manufacturing tested and manufactured under a Quality Management System certified to ISO 9001:2008 in order to assure consistent high quality.

Features	Benefits
Fully disposable capsule with Luer connections	Easy handling, ready to use
Pegasus SV4 virus removal filter membrane	Robust, high > 4 LRV parvovirus virus clearance
Constant flow and high throughput performance	Maximize virus filter process economy as well as efficiency
Identical membrane to larger production scale Pegasus SV4 virus filter cartridges	Offers reliable scalability
Individual capsules identified by lot and serial number	Easy identification of individual capsules with complete traceability of manufacturing history
100% manufacturing assembly tested	Assurance of consistently high quality
Membrane bacteriophage tested	Assurance of consistently high quality
Pre- and post-use installation testable	Assurance of consistently high quality at point of use
Low protein-binding	High protein recovery
Robust membrane with high viral clearance	Flow decay minimized at high virus spike concentrations and with complex or concentrated feeds

High Quality Standards

• Meets the current USP requirements under Section <85> Bacterial Endotoxins Test.

Materials

• Filter fluid path components have met the specifications under Section <88> Biological Reactivity Tests in vivo listed in the current revision of the United States Pharmacopeia (USP) for Class VI plastics at 121 °C.